Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate

Acta Tropica

Volumn 113, Issue 2, 2010, Pages 190-194

  Chaijaroenkul, Wanna ^a   Wisedpanichkij, Raewadee ^a   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Drug resistance; Gene copy number; pfcrt; pfmdr1; Plasmodium falciparum

Indexed keywords

ARTESUNATE; CHLOROQUINE; MEFLOQUINE; MOLECULAR MARKER; QUININE;

DRUG RESISTANCE; MALARIA; MONITORING; MUTATION; OBSERVATIONAL METHOD; POLYMORPHISM; QUININE; SENSITIVITY ANALYSIS;

ARTICLE; CROSS RESISTANCE; DNA POLYMORPHISM; DRUG MONITORING; DRUG RESISTANCE; DRUG SENSITIVITY; GENE AMPLIFICATION; IN VITRO STUDY; MALARIA FALCIPARUM; MOLECULAR MECHANICS; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POINT MUTATION; PREVALENCE; PROTOZOAL GENETICS; STRAIN DIFFERENCE;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG RESISTANCE; GENE DOSAGE; GENETIC MARKERS; MALARIA, FALCIPARUM; MEFLOQUINE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYANMAR; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; QUININE; THAILAND;

THAILAND;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 74249093886     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.10.016     Document Type: Article

References (42)

1. Alker A.P., Lim P., Sem R., Shah N.K., Yi P., Bouth D.M., Tsuyuoka R., Maguire J.D., Fandeur T., Ariey F., Wongsrichanalai C., and Meshnick S.R. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am. J. Trop. Med. Hyg. 76 (2007) 641-647
2. Bennett T.N., Paguio M., Gligorijevic B., Seudieu C., Kosar A.D., Davidson E., and Roepe P.D. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob. Agents Chemother. 48 (2004) 1807-1810
3. + exchanger activity and quinine resistance. Mol. Biochem. Parasitol. 153 (2007) 48-58
4. Carrara V.I., Zwang J., Ashley E.A., Price R.N., Stepniewska K., Barends M., Brockman A., Anderson T., McGready R., Phaiphun L., Proux S., van Vugt M., Hutagalung R., Lwin K.M., Phyo A.P., Preechapornkul P., Imwong M., Pukrittayakamee S., Singhasivanon P., White N.J., and Nosten F. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4 (2009) e4551
5. Ceruttij, Junior C., Marques C., Alencar F.E., Durlacher R.R., Alween A., Segurado A.A., Pang L.W., and Zalis M.G. Antimalarial drug susceptibility testing of Plasmodium falciparum in Brazil using a radioisotope method. Mem. Inst. Oswaldo. Cruz. 94 (1999) 803-809
6. Chaijaroenkul W., Na-Bangchang K., Mungthin M., and Ward S.A. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003. Malar. J. 4 (2005) 37
7. Chaiyaroj S.C., Buranakiti A., Angkasekwinai P., Looressuwan S., and Cowman A.F. Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand. Am. J. Trop. Med. Hyg. 61 (1999) 780-783
8. Chen N., Kyle D.E., Pasay C., Fowler E.V., Baker J., Peters J.M., and Cheng Q. Pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob. Agents Chemother. 47 (2003) 3500-3505
9. Chen N., Russell B., Staley J., Kotecka B., Nasveld P., and Cheng Q. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. J. Infect. Dis. 183 (2001) 1543-1545
10. Congpuong K., Na-Bangchang K., Mungthin M., Bualombai P., and Wernsdorfer W.H. Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand. Trop. Med. Int. Health 10 (2005) 717-722
11. Cooper R.A., Ferdig M.T., Su X.Z., Ursos L.M., Mu J., Nomura T., Fujioka H., Fidock D.A., Roepe P.D., and Wellems T.E. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 61 (2002) 35-42
12. Djimde A., Doumbo O.K., Cortese J.F., Kayentao K., Doumbo S., Diourte Y., Dicko A., Su X.Z., Nomura T., Fidock D.A., Wellems T.E., Plowe C.V., and Coulibaly D. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344 (2001) 257-263
13. Duraisingh M.T., and Cowman A.F. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 94 (2005) 181-190
14. Duraisingh M.T., Jones P., Sambou I., von Seidlein L., Pinder M., and Warhurst D.C. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisisnin. Mol. Biochem. Parasitol. 108 (2000) 13-23
15. Ferdig M.T., Cooper R.A., Mu J., Deng B., Joy D.A., Su X.Z., and Wellems T.E. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52 (2004) 985-997
16. Ferreira I.D., Rosario V.E., and Cravo P.V. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malar. J. 5 (2006) 1
17. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naude B., Deitsch K.W., Su X.Z., Wootton J.C., Roepe P.D., and Wellems T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6 (2000) 861-871
18. Foote S.J., and Kemp D.J. Chromosomes of malaria parasites. Trends Genet. 5 (1989) 337-342
19. Guerin P.J., Bates S.J., and Sibley C.H. Global resistance surveillance: ensuring antimalarial efficacy in the future. Curr. Opin. Infect. Dis. 22 (2009) 593-600
20. Johnson D.J., Fidock D.A., Mungthin M., Lakshmanan V., Sidhu A.B., Bray P.G., and Ward S.A. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell 15 (2004) 867-877
21. Labbe A.C., Patel S., Crandall I., and Kain K.C. A molecular surveillance system for global patterns of drug resistance in imported malaria. Emerg. Infect. Dis. 9 (2003) 33-36
22. Lim P., Alker A.P., Khim N., Shah N.K., Incardona S., Doung S., Yi P., Bouth D.M., Bouchier C., Puijalon O.M., Meshnick S.R., Wongsrichanalai C., Fandeur T., Le Bras J., Ringwald P., and Ariey F. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 8 (2009) 11
23. Mita T., Kaneko A., Lum J.K., Bwijo B., Takechi M., Zungu I.L., Tsukahara T., Tanabe K., Kobayakawa T., and Bjorkman A. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am. J. Trop. Med. Hyg. 68 (2003) 413-415
24. Mu J., Ferdig M.T., Feng X., Joy D.A., Duan J., Furuya T., Subramanian G., Aravind L., Cooper R.A., Wootton J.C., Xiong M., and Su X.Z. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 49 (2003) 977-989
25. Na-Bangchang K., and Congpuong K. Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand. Tohoku J. Exp. Med. 211 (2007) 99-113
26. Nelson A.L., Purfield A., McDaniel P., Uthaimongkol N., Buathong N., Sriwichai S., Miller R.S., Wongsrichanalai C., and Meshnick S.R. Pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Am. J. Trop. Med. Hyg. 72 (2005) 586-592
27. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., and Fukuda M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359 (2008) 2619-2620
28. Peel S.A., Bright P., Yount B., Handy J., and Baric R.S. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51 (1994) 648-658
29. Pickard A.L., Wongsrichanalai C., Purfield A., Kamwendo D., Emery K., Zalewski C., Kawamoto F., Miller R.S., and Meshnick S.R. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47 (2003) 2418-2423
30. Price R.N., Cassar C., Brockman A., Duraisingh M., Van Vugt M., White N.J., Nosten F., and Krishna S. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43 (1999) 2943-2949
31. Price R.N., Uhlemann A.C., Brockman A., McGready R., Ashley E., Phaipun L., Patel R., Laing K., Looareesuwan S., White N.J., Nosten F., and Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364 (2004) 438-447
32. Raj D.K., Mu J., Jiang H., Kabat J., Singh S., Sullivan M., Fay M.P., McCutchan T.F., and Su X.Z. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J. Biol. Chem. 284 (2009) 7687-7696
33. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., and Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403 (2000) 906-909
34. Rogers W.O., Sem R., Tero T., Chim P., Lim P., Muth S., Socheat D., Ariey F., and Wongsrichanalai C. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J. 8 (2009) 10
35. Sidhu A.B., Uhlemann A.C., Valderramos S.G., Valderramos J.C., Krishna S., and Fidock D.A. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194 (2006) 528-535
36. Smilkstein M., Sriwilaijaroen N., Kelly J.X., Wilairat P., and Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48 (2004) 1803-1806
37. (+) exchanger. Mol. Biochem. Parasitol. 162 (2008) 96-99
38. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
39. Vijaykadga S., Rojanawatsirivej C., Cholpol S., Phoungmanee D., Nakavej A., and Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop. Med. Int. Health 11 (2006) 211-219
40. Wilson C.M., Volkaman S.K., Thaithong S., Martin R.K., Kyle D.E., Milhous W.K., and Wirth D.F. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57 (1993) 151-160
41. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., and Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2 (2002) 209-218
42. Wooden J., Kyes S., and Sibley C.H. PCR and strain identification in Plasmodium falciparum. Parasitol. Today 9 (1993) 303-305